Mexiletine: An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder

Nour K. Kadouh, Stacy Lang, Mark Shamoun, Eric L. Scott, Sharon A. Singh, Michael A. Smith

Research output: Contribution to journal › Letter › peer-review

Access to Document

@article{53efdb99e02c45189bbd14823fdc8c13,

title = "Mexiletine: An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder",

author = "Kadouh, {Nour K.} and Stacy Lang and Mark Shamoun and Scott, {Eric L.} and Singh, {Sharon A.} and Smith, {Michael A.}",

year = "2022",

month = aug,

doi = "10.1002/pbc.29526",

language = "English",

volume = "69",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

number = "8",

}

TY - JOUR

T1 - Mexiletine

T2 - An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder

AU - Kadouh, Nour K.

AU - Lang, Stacy

AU - Shamoun, Mark

AU - Scott, Eric L.

AU - Singh, Sharon A.

AU - Smith, Michael A.

PY - 2022/8

Y1 - 2022/8

UR - http://www.scopus.com/inward/record.url?scp=85122021009&partnerID=8YFLogxK

U2 - 10.1002/pbc.29526

DO - 10.1002/pbc.29526

M3 - Letter

AN - SCOPUS:85122021009

SN - 1545-5009

VL - 69

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 8

M1 - e29526

ER -